ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

COCP Cocrystal Pharma Inc

1.59
0.06 (3.92%)
May 02 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cocrystal Pharma Inc COCP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.06 3.92% 1.59 17:31:55
Open Price Low Price High Price Close Price Previous Close
1.53 1.52 1.59 1.59 1.53
more quote information »

Recent News

Date Time Source Heading
5/01/202407:00GLOBEEnrollment Completed in Phase 2a Study with Cocrystal..
3/28/202407:00GLOBECocrystal Pharma Reports 2023 Financial Results and Provides..
3/19/202407:00GLOBECocrystal Pharma Receives Pre-IND Responses from the FDA on..
3/01/202415:15EDGAR2Form 8-K - Current report
1/08/202407:00EDGAR2Form 8-K - Current report
1/04/202415:01EDGAR2Form 8-K - Current report
1/04/202407:00GLOBECocrystal Pharma Provides an Update on the Clinical..
1/02/202408:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/21/202316:00EDGAR2Form 8-K - Current report
12/06/202307:00EDGAR2Form 8-K - Current report
12/06/202307:00GLOBECocrystal Pharma Announces First-Patient-In for Phase 2a..
12/04/202307:00EDGAR2Form 8-K - Current report
11/29/202307:00EDGAR2Form 8-K - Current report
11/29/202307:00GLOBECocrystal Pharma Highlights its Novel Inhaled and Oral..
11/27/202307:00GLOBECocrystal Pharma to Present at the NobleCon 19 Conference on..
11/13/202307:15EDGAR2Form 8-K - Current report
11/13/202307:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202307:00GLOBECocrystal Pharma Reports Third Quarter 2023 Financial..
11/09/202307:00GLOBECocrystal Pharma to Discuss Progress with Novel Inhaled and..
10/31/202307:00EDGAR2Form 8-K - Current report
10/31/202307:00GLOBECocrystal Pharma Receives UK MHRA Authorization to Initiate..
9/28/202307:00GLOBECocrystal Pharma Doses First Subjects in Clinical Study of..
9/05/202307:00GLOBECocrystal Pharma to Participate in the H.C. Wainwright..
8/16/202315:05EDGAR2Form 8-K - Current report
8/14/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202307:00GLOBECocrystal Pharma Reports Second Quarter 2023 Financial..
8/08/202307:00GLOBECocrystal Pharma Selects Novel Oral Protease Inhibitor..
7/20/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/20/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/20/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/20/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/31/202307:00GLOBECocrystal Pharma Receives HREC Approval to Initiate Phase 1..
5/15/202307:00GLOBECocrystal Pharma Reports First Quarter 2023 Financial..
5/04/202315:05GLOBECocrystal Pharma Presents New Data from its CC-42344 Phase 1..

Your Recent History

Delayed Upgrade Clock